AP Moeller - Maersk A/S B (0O77)
London Exchange · UK · prices in DKK · close of 23 Oct 2026
Key indicators
| Last close | DKK 22,680.00 |
|---|---|
| 52-week range | 12,050.00 – 25,240.00 |
| Return, 1 month / 3 months | −1.5% / +31.5% |
| Return, 1 year / 3 years | +78.6% / +141.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 40.5% |
| Worst drawdown (1 year) | -23.2% |
| Average daily value traded | 20.54M DKK |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
A.P. Moller - Maersk is a Danish transport and logistics company based in Copenhagen. Its main activity is container shipping, moving goods across the world's oceans for manufacturers, retailers and other businesses that trade internationally. The company also runs port terminals and offers freight forwarding, customs and supply chain services, so customers can arrange door-to-door transport through one provider. It serves exporters, importers and industrial firms in many countries.
On this site AP Moeller - Maersk A/S B appears as a stock on the London Exchange (UK), code 0O77, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AP Moeller - Maersk A/S B (0O77) trades on the London Exchange in UK. It last closed at DKK 22,680.00 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 289 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 78.6% and over the last three months it rose 31.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 28.7% | ||
| From 52-week high | -8.6% | ||
| Momentum | 94 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 31.5% | ||
| 6-month return | 53.2% | ||
| 12-month return, skipping the last month | 81.2% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.2% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 20.54M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.9% |
|---|---|
| 1 month | −1.5% |
| 3 months | +31.5% |
| 6 months | +53.2% |
| 1 year | +78.6% |
| 3 years | +141.4% |
| 5 years | +106.0% |
Signals
| 50-day / 200-day average | 22,909.65 / 17,628.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 690.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | DKK 480.0000 |
| 19 Mar 2025 | DKK 1,120.0000 |
| 15 Mar 2024 | DKK 495.5569 |
| 29 Mar 2023 | DKK 2,213.1666 |
| 16 Mar 2022 | DKK 2,405.6159 |
| 24 Mar 2021 | DKK 317.5413 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.